(Q28318920)

2

0 references

J M Rouillon

3

0 references

P Peray

4

0 references

R Pierrugues

5

0 references

D Larrey

6

0 references

F Gremy

7

0 references

H Michel

Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose

8

0 references

language of work or name

English

0 references

publication date

February 1992

0 references

published in

Hepatology

0 references

volume

15

0 references

issue

2

0 references

page(s)

222-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Resolving conflicting clinical trials: Guidelines for meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

A comparison of statistical methods for combining event rates from clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150209

7 January 2021

Identifiers

DOI

10.1002/HEP.1840150209

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3864830

OpenCitations bibliographic resource ID

3864830

1 reference